SMCI Investigation Sparks Rally—Should Investors Be Concerned About Lingering Issues?
Wholesale Inflation Surges to 3%, Complicating Fed’s Rate Cut Outlook
Wholesale prices surged more than anticipated in November, with the Producer Price Index (PPI) rising 3% year-over-year, according to the Bureau of Labor Statistics (BLS).
The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics
Stock Market Today: Stocks Mixed Amid Fresh Jobs Data and Awaiting Fed Clarity
Business & Market Movers
Breaking News
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform. The U.S. Patent and Trademark Office (USPTO) has issued U.S. patent # 11,898,184, entitled “Low Glycemic Sugar Composition” developed within this platform.
Bruush Oral Care Inc. and Arrive Technology Inc. Announce Agreement and Plan of Merger
scdadmin·Dec 15, 2023
Deep Dive & Research
Healthcare & Biotech
The Biotech Stock Soaring 63% on Unprecedented Cancer Trial Results – Meet Janux Therapeutics
On December 3, 2024, the company announced groundbreaking results for its lead drug candidate, JANX007, a tumor-activated T-cell engager targeting advanced-stage prostate cancer.
Join our newsletter
Read and share new perspectives on just about any topic. Everyone’s welcome.- 01Create a free account
- 02Write your story
Tech & Energy
SMCI Investigation Sparks Rally—Should Investors Be Concerned About Lingering Issues?
SMCI’s shares surged after an independent investigation found no evidence of fraud and the special committee’s recommendation to strengthen governance has calmed some investor fears.
